Screening for biopterin defects in newborns with phenylketonuria and other hyperphenylalaninemias

Reuben Matalon, K. Michals, C. L. Lee, J. C. Nixon

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The newborn screening for phenylketonuria (PKU) has become a common practice in many countries. The success of this type of mass screening is the result of the reliability of the Guthrie test in the identification of high blood phenylalanine levels. Recently, new syndromes other than PKU have been recognized that give high blood phenylalanine levels. These syndromes are referred to as 'atypical' PKU. While in classical PKU phenylalanine hydroxylase is the deficient enzyme, in the atypical forms of PKU the deficiency is in the enzymes affecting the production of tetrahydrobiopterin, the cofactor required for the activity of phenylalanine hydroxylase. Two types of atypical forms of PKU are now known. One is caused by a deficiency of dihydropteridine reductase, and the other is caused by defects in the synthetic pathways of biopterin, termed as 'biopterin synthetase deficiency'. In addition, a transient form of biopterin synthetase deficiency occurs in the newborn period which has to be distinguished from the permanent defect in biopterin synthesis. Analysis of oxidized pterins in urine by high performance liquid chromatography identifies classical PKU, dihydropteridine reductase deficiency, and biopterin synthetase defects. The early recognition of these cofactor defects is essential for the successful treatment of patients with the atypical forms of hyperphenylalaninemias.

Original languageEnglish (US)
Pages (from-to)411-414
Number of pages4
JournalAnnals of Clinical and Laboratory Science
Volume12
Issue number5
StatePublished - 1982
Externally publishedYes

Fingerprint

Biopterin
Phenylketonurias
Screening
Newborn Infant
Dihydropteridine Reductase
Ligases
Defects
Phenylalanine Hydroxylase
Phenylalanine
Blood
Pterins
High performance liquid chromatography
Enzymes
Mass Screening
Reproducibility of Results
High Pressure Liquid Chromatography
Urine

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Clinical Biochemistry

Cite this

Screening for biopterin defects in newborns with phenylketonuria and other hyperphenylalaninemias. / Matalon, Reuben; Michals, K.; Lee, C. L.; Nixon, J. C.

In: Annals of Clinical and Laboratory Science, Vol. 12, No. 5, 1982, p. 411-414.

Research output: Contribution to journalArticle

@article{ba8e0298df84461b952dbbefaf425867,
title = "Screening for biopterin defects in newborns with phenylketonuria and other hyperphenylalaninemias",
abstract = "The newborn screening for phenylketonuria (PKU) has become a common practice in many countries. The success of this type of mass screening is the result of the reliability of the Guthrie test in the identification of high blood phenylalanine levels. Recently, new syndromes other than PKU have been recognized that give high blood phenylalanine levels. These syndromes are referred to as 'atypical' PKU. While in classical PKU phenylalanine hydroxylase is the deficient enzyme, in the atypical forms of PKU the deficiency is in the enzymes affecting the production of tetrahydrobiopterin, the cofactor required for the activity of phenylalanine hydroxylase. Two types of atypical forms of PKU are now known. One is caused by a deficiency of dihydropteridine reductase, and the other is caused by defects in the synthetic pathways of biopterin, termed as 'biopterin synthetase deficiency'. In addition, a transient form of biopterin synthetase deficiency occurs in the newborn period which has to be distinguished from the permanent defect in biopterin synthesis. Analysis of oxidized pterins in urine by high performance liquid chromatography identifies classical PKU, dihydropteridine reductase deficiency, and biopterin synthetase defects. The early recognition of these cofactor defects is essential for the successful treatment of patients with the atypical forms of hyperphenylalaninemias.",
author = "Reuben Matalon and K. Michals and Lee, {C. L.} and Nixon, {J. C.}",
year = "1982",
language = "English (US)",
volume = "12",
pages = "411--414",
journal = "Annals of Clinical and Laboratory Science",
issn = "0091-7370",
publisher = "Association of Clinical Scientists",
number = "5",

}

TY - JOUR

T1 - Screening for biopterin defects in newborns with phenylketonuria and other hyperphenylalaninemias

AU - Matalon, Reuben

AU - Michals, K.

AU - Lee, C. L.

AU - Nixon, J. C.

PY - 1982

Y1 - 1982

N2 - The newborn screening for phenylketonuria (PKU) has become a common practice in many countries. The success of this type of mass screening is the result of the reliability of the Guthrie test in the identification of high blood phenylalanine levels. Recently, new syndromes other than PKU have been recognized that give high blood phenylalanine levels. These syndromes are referred to as 'atypical' PKU. While in classical PKU phenylalanine hydroxylase is the deficient enzyme, in the atypical forms of PKU the deficiency is in the enzymes affecting the production of tetrahydrobiopterin, the cofactor required for the activity of phenylalanine hydroxylase. Two types of atypical forms of PKU are now known. One is caused by a deficiency of dihydropteridine reductase, and the other is caused by defects in the synthetic pathways of biopterin, termed as 'biopterin synthetase deficiency'. In addition, a transient form of biopterin synthetase deficiency occurs in the newborn period which has to be distinguished from the permanent defect in biopterin synthesis. Analysis of oxidized pterins in urine by high performance liquid chromatography identifies classical PKU, dihydropteridine reductase deficiency, and biopterin synthetase defects. The early recognition of these cofactor defects is essential for the successful treatment of patients with the atypical forms of hyperphenylalaninemias.

AB - The newborn screening for phenylketonuria (PKU) has become a common practice in many countries. The success of this type of mass screening is the result of the reliability of the Guthrie test in the identification of high blood phenylalanine levels. Recently, new syndromes other than PKU have been recognized that give high blood phenylalanine levels. These syndromes are referred to as 'atypical' PKU. While in classical PKU phenylalanine hydroxylase is the deficient enzyme, in the atypical forms of PKU the deficiency is in the enzymes affecting the production of tetrahydrobiopterin, the cofactor required for the activity of phenylalanine hydroxylase. Two types of atypical forms of PKU are now known. One is caused by a deficiency of dihydropteridine reductase, and the other is caused by defects in the synthetic pathways of biopterin, termed as 'biopterin synthetase deficiency'. In addition, a transient form of biopterin synthetase deficiency occurs in the newborn period which has to be distinguished from the permanent defect in biopterin synthesis. Analysis of oxidized pterins in urine by high performance liquid chromatography identifies classical PKU, dihydropteridine reductase deficiency, and biopterin synthetase defects. The early recognition of these cofactor defects is essential for the successful treatment of patients with the atypical forms of hyperphenylalaninemias.

UR - http://www.scopus.com/inward/record.url?scp=0019940726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019940726&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 411

EP - 414

JO - Annals of Clinical and Laboratory Science

JF - Annals of Clinical and Laboratory Science

SN - 0091-7370

IS - 5

ER -